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ABSTRACT 
 
Mature osteoclasts, multinucleated giant cells responsible for bone resorption, are terminally differentiated cells with a 
short life span. Recently, we have demonstrated that osteoclast apoptosis is regulated by ERK activity and Bcl-2 family 
member Bim. In this paper, we summarize the methods we used to study osteoclast apoptosis in vitro and in vivo. 
Using adenovirus and retrovirus vectors, we were able to introduce foreign genes into osteoclasts and examine their 
effects on osteoclast survival in vitro. In addition, we established the modified methods for in situ hybridization and 
BrdU labeling of bone sections from mice to study osteoclast survival in vivo. The detailed methods described here 
could be useful for studying the biological process in bone. 
 
 
INTRODUCTION 
 
Osteoclasts, terminally differentiated cells with a short 
life span, are multinucleated giant cells primarily 
responsible for bone resorption (1). They undergo rapid 
apoptosis in the absence of trophic factors such as 
macrophage colony-stimulating factor (M-CSF) and 
receptor activator of NF-κB ligand (RANKL) (2). 
However, the molecular events implicated in these 
processes still remain elusive. 
 
Apoptosis is the genetically programmed cell death to 
remove the unwanted cells (3). The abnormalities of 
apoptosis regulation induce various sicknesses such as 
cancer, autoimmune diseases and degenerative disorders 
(4). There are two distinct apoptosis signal pathways in 
mammals. One pathway is initiated by death receptors, 
members of tumor necrosis factor receptor (TNF-R) 
family. The other pathway is regulated by pro- and anti- 
 
 
apoptotic Bcl-2 family member via mitochondrial release 
of cytochrome c and caspase-9 activation (5, 6). The anti-
apoptotic Bcl-2 family members include mammalian Bcl-
2 and Bcl-xL and they share similarity within three or 
four Bcl-2 homology (BH) domains. So far, more than 20 
pro-apoptotic Bcl-2 family proteins have been identified 
in mammals. They can be further divided into 2 groups: 
multi-domain members possess homology in two or 
three BH regions, such as Bax and Bak, whereas the BH3 
domain-only proteins, such as Bad, Bid and Bim/Bod, 
share only the short BH3 region (7). The pro-apoptotic 
activity of BH3-only proteins is strictly regulated at both 
the transcriptional and post-translational level to prevent 
inappropriate cell death (7). 
 
The BH3-only protein Bim was first identified as a Bcl-2-
interacting protein by screening a λ phage expression 
library constructed from mouse thymic lymphoma cells 
(8). Bim is expressed in hematopoietic, epithelial,     
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neuronal and germ cells (9), and alternative splicing 
generates various Bim isoforms, including Bims, BimL 
and BimEL. Experiments with knock-out mice have 
shown that Bim is essential for apoptosis of T 
lymphocytes, B lymphocytes, myeloid cells and neurons 
(10-14). Pro-apoptotic activity of Bim is regulated both 
transcriptionally and post-transcriptionally (7). We 
recently showed that ubiquitin-dependent regulation of 
Bim levels is critical for controlling osteoclast apoptosis 
(15). 
 
The purpose of this paper is to summarize approaches 
recently developed and optimized to study molecular 
mechanism of osteoclast apoptosis in vitro and in vivo. 
We developed protocols of adenovirus- and retrovirus-
mediated gene transduction systems for mature 
osteoclasts and osteoclast precursors, respectively. 
Furthermore, we established the optimal protocols for in 
situ hybridization and BrdU labeling of bone sections 
from mice to study osteoclast life span in vivo. These 
assays can be used to understand how bone homeostasis 
is maintained. 
 
MATERIALS AND METHODS 
 
Antibodies and chemicals 
 
Antibodies to Bid and Bax were purchased from Cell 
Signaling Technology. (Beverly, MA). We used three 
different antibodies to Bim in this study, i.e. M-20 (Sant 
Cruz Technology, Santa Cruz, CA) for 
immunoprecipitation, anti-Bim monoclonal antibody 
(BD Bioscience Pharmingen, San Jose, CA) for Western 
blotting, and anti-Bim polyclonal antibody (Oncogene 
Research Products Cambridge, MA) for 
immunocytochemistry. Anti-Bcl-xL and anti-ubiquitin 
were from Santa Cruz Technology. Recombinant mouse 
M-CSF was obtained from TECHNE Co. (Minneapolis, 
MN) and soluble RANKL was from Wako Pure Chemical 
Co. (Osaka, Japan). Alpha modified-minimum essential 
medium (αMEM) was purchased from GIBCO BRL, Life 
Technologies Inc. (Rockville, MD), and fetal bovine 
serum (FBS) was from Sigma (St. Louis, MO). Bacterial 
collagenase was purchased from Wako Pure Chemical 
Co. (Osaka, Japan), 1α,25(OH)2D3 from Calbiochem(La 
Jolla, CA) and dispase from Godoshusei (Tokyo, Japan). 
The broad-spectrum caspase inhibitor zVAD-FMK was 
from Calbiochem (La Jolla, CA). Alexa 488 and 568 
labeled antibodies to rabbit IgG, Mitotracker® Green, 
MitoTracker® Red and Hoechst 33342 were purchased 
from MolecularProbes (Eugene, OR). ApoAlert® Cell 
Fraction Kit was purchased from BD Biosciences 
Clontech (Palo Alto, CA). Other chemicals and reagents 
used in this study were of analytical grade. 
 
Construction and gene transduction of adenovirus 
vectors 
 
The recombinant adenovirus vectors carrying either 
constitutively active MEK1 (ser218 and Ser222 to Glu, 
AxMEK1CA), dominant negative Ras (Ser17 to Asn, 
AxRasDN), myristoylated Akt (The Src myristoylation 
sequence was added to Akt Δ4-129, myr-Akt) or 
enhanced green fluorescent protein (EGFP) gene under 
the control of the CAG (cytomegalovirus IE enhancer + 
chicken  β-actin promoter + rabbit β-globin poly (A)+ 
signal promoter) was constructed by homologous 
recombination between expression cosmid cassette and 
the parental virus genome in 293 cells (16). Adenovirus 
vector expressing BimL under the control of the CMV 
promoter was constructed using Adeno-X™ Adenoviral 
Expression Systems from BD Biosciences Clontech (Palo 
Alto, CA). Titers of virus stocks were determined by 
endpoint cytopathic effect assay with the following 
modifications (17). 50 µl of DMEM/10%FBS was 
dispensed into each well of a 96-well tissue culture plate, 
and then eight rows of three fold serial dilutions of the 
virus starting from 10-4 dilutions were prepared. 3 x 105 
293 cells in 50 µl of DMEM/10%FBS was added to each 
well every 3d. 12 days later, the endpoint of the 
cytopathic effect was determined by microscopy, and the 
50% tissue culture infectious dose (TCID50) was 
calculated. One TCID50/ml approximately corresponds to 
one plaque forming unit (PFU)/ml (17). The efficiency of 
infection is affected not only by the concentration but 
also by the ratio of viruses to cells, the multiplicity of 
infection (MOI). In this study, MOI is expressed as a 
measure of titer how many PFUs of viruses were added 
to every cell. Mouse cocultures on day 5, when OCLs 
began to appear, were incubated with a small amount of 
αMEM containing the recombinant adenoviruses for 1 h 
at 37°C at an indicated MOI. The cells were washed twice 
with PBS and further incubated with αMEM/10%FBS at 
37°C. Experiments were performed 24 h after the 
infection.  
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Construction and gene transduction of retroviral 
vectors 
 
Retroviral vectors, pMx-BimEL-IRES-EGFP and pMx-
mtBimEL-IRES-EGFP were constructed by inserting full-
length mouse cDNA of bimEL  and mutated bimEL, in 
which the two ubiquitin acceptor lysine residues (Lys3 
and Lys108) were mutated to arginine, into pMx-IRES-
EGFP vector (provided by Dr. Kitamura). Retrovirus 
packaging was performed by transfection of the pMx 
vectors into packaging cell line BOSC23 (2 x 106) cells. 
Virus stocks were prepared by collecting the media from 
cultures 48 h after transfection. Mouse bone marrow 
macrophage cells (3 x 105) were incubated with 3 ml of 
virus stock for 4 h in the presence of mouse recombinant 
M-CSF (50 ng/ml) and polybrene (8 µg/ml). Cells were 
washed twice with PBS and further incubated in the 
presence of 100 ng/ml M-CSF. Experiments were 
performed 7 days after the infection.  
 
Animals, cells and cultures 
 
Newborn ddY mice and 8-week-old male ddY mice were 
purchased from Shizuoka Laboratories Animal Center 
(Shizuoka, Japan). The breeding and genotyping of bim-/- 
mice (Chimeric mouse were bred to C57BL/6 mice. 
Heterozygous mice were interbred more than 12 times. 
The genetic background was same as C57BL/6 mice) was 
performed as previously described (10). The transgenic 
mice in which a reporter lacZ gene was introduced into 
the  bim locus was generated by homologous 
recombination. To obtain large numbers of cells for 
biochemical analyses, we utilized the co-culture system 
established by Takahashi et al. (18). Mouse primary 
osteoblastic cells were obtained from 1-day-old mouse 
calvaria by enzymatic digestion and bone marrow cells 
were from tibiae of adult mice. Osteoblastic cells (5 x 105 
cells/dish) were co-cultured with bone marrow cells (1 x 
107 cells/dish) on 10 cm dishes or collagen gel-coated 
dishes in the presence of 10 nM 1α,25(OH)2D3 and 1 µM 
PGE2. For protein analysis, OCLs were purified following 
a modification of the method originally reported by 
Tezuka et al. (19). The crude OCL preparation placed on 
plastic dishes was washed with αMEM, and treated with 
5 ml of αMEM containing 0.1% collagenase and 0.2% 
d i s p a s e  f o r  1 0  m i n  t o  r e m o v e  o s t e o b l a s t i c  c e l l s .  T h e  
purity of OCLs and their precursors was more than 90% 
at the final preparation. 
 
Survival of OCLs 
 
OCLs were purified 24 h after the infection and some of 
the cultures were subjected to tartrate-resistant acid 
phosphatase (TRAP) staining. Osteoclasts adhere to the 
bone surface through specialized discrete structures 
called “podosomes” in the clear zone, which consist 
mainly of dots containing F-actin. The rounded and 
spreaded appearance with ringed structure of 
podosomes (actin ring) is a characteristic of polarized 
osteoclasts. Cell viability/survival is expressed as 
morphologically intact TRAP-positive multinucleated 
cells. Other cultures were further incubated for the 
indicated times, and then the number of living OCLs was 
counted. The number of viable cells remaining at the 
different time points is shown as a percentage of the cells 
at time zero (20). 
 
DNA extraction and electrophoretic analysis 
 
Purified OCLs were lysed by incubating at 60°C 
overnight in a digestion buffer containing 150 mM NaCl, 
25 mM EDTA, 100 µg/ml proteinase K, and 0.2% SDS. 
The DNA was extracted twice with 
phenol/chloroform/isoamylalcohol and once with 
chloroform, and precipitated in ethanol with 150 mM 
CH3COONa, pH 5.2. The DNA was dissolved in TE 
buffer (10 mM Tris-HCl, pH 8.0, and 1 mM EDTA) and 
treated with 20 mg/ml RNase A. The procedure for DNA 
extraction and precipitation were repeated. 2 µg of DNA 
was separated by electrophoresis on a 1.5% agarose gel 
and visualized by ethidium bromide staining with UV 
light illumination (21). 
 
TUNEL assay  
 
Cells undergoing apoptosis were identified by means of 
the TdT-mediated dUTP-dioxigenin nick-end labeling 
(TUNEL) method, which specifically labels the 3’-
hydroxyl terminal of DNA strand breaks. For the TUNEL 
procedure, all agents, including buffers, were part of a 
kit (Apoptosis in situ Detection KIT, Wako Pure 
Chemical Co.); the staining procedure was carried out 
according to the manufacturer’s recommendation. 
Negative controls included omission of TdT. Positive 
controls included treatment of the samples with DNase I. 
Apoptotic cells were recognized by their dark nuclear     
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staining (TUNEL-positive) and nuclei of non-apoptotic 
cells were visualized by staining with methyl green. 
 
Western blotting 
 
Cells were washed twice with ice-cold PBS and lysed in 
lysis buffer [20 mM Tris-HCl (pH7.5), 150 mM NaCl, 1% 
TritonX-100, 12 mM β-glycerophosphate, 5 mM EGTA, 
0.5% deoxycholate, 3 mM DTT, 10 mM NaF, 1 mM 
Na3VO4, 2 µM leupeptin, 20 µg/ml aprotinin, and 1 mM 
PMSF]. After 30 min incubation on ice, cell lysates were 
cleared by centrifugation at 12,000 x g for 20 min. An 
equal amount (20 µg per lane) of protein was 
fractionated on 4-20% gradient SDS-PAGE gels under 
reducing conditions, transferred electrophoretically onto 
PVDF membranes, and probed sequentially with an 
appropriate primary antibody followed by secondary 
antibodies coupled to horseradish peroxidase (Promega 
Co., Madison, WI). Immunoreactive proteins were 
visualized using ECL Western blotting detection 
reagents (Amersham Co., Arlington Heights, IL) 
following the procedures recommended by the supplier. 
The blots were stripped by incubating for 20 min in 
stripping buffer [2% SDS, 100 mM 2-mercaptoethanol, 
62.5 mM Tris-HCl (pH 6.7)] at 50°C and reprobed by 
other antibodies. 
 
Ubiquitylation assay 
 
2 x 106 Cells were washed three times with PBS and the 
medium was changed to fresh αMEM/10% FBS with 50 
ng/ml M-CSF, 50 µM MG132, or 20 µM lactacystin. 
Twelve hours after changing medium, cells were washed 
three times with PBS and lysed in lysis buffer [20 mM 
Hepes-NaOH (pH 7.4), 150 mM NaCl, 10 mM EDTA, 1 
mM Na3VO4, and 1 mM PMSF, 0.05% NP-40, 10% 
glycerol] cell lysates were homogenized by pipetting 
with 1 ml silinge and 26G needle more than 50 times. 
After homogenization, cellular debris was pelleted by 
centrifugation at 12,000 x g for 20 min. Supernatants (cell 
l y s a t e s )  w e r e  p r e c l e a r e d  b y  a d d i n g  2 0  µ l  o f  p r o t e i n - A  
agarose. Immunoprecipitation was performed by 
incubating 500 µl of cell lysate with 2 µg of anti-Bim 
antibody for 2 h, then adding 20 µl of protein-A agarose. 
After incubation for 1 h at 4°C with end-over-end 
mixing, the immune complexes were recovered by 
centrifugation and washed twice with washing buffer [20 
mM Tris-HCl (pH7.5), 150 mM NaCl, 5 mM EGTA, 2 mM 
DTT, and 1 mM PMSF]. The immunoprecipitates were 
then subjected to SDS-PAGE and immunoblotted with 
anti-ubiquitin antibody. 
 
Immunofluorescence 
 
For immunofluorescence analysis, cells were plated on 
sterile FBS-coated glass coverslips and purified by 
treatment with αMEM containing 0.1% collagenase and 
0.2% dispase. After purification, OCLs were fixed in 3.7% 
(vol/vol) formaldehyde in PBS for 10 min, and then 
washed three times in PBS. Cells were permeabilized in 
0.05% saponin for 30 min, and blocked in 5% normal goat 
serum (Boehringer) for 30 min and incubated in 
appropriate primary antibodies, washed in PBS, 
incubated with fluorescein-conjugated secondary 
antibody, and finally washed in PBS and mounted in 
FluorSave. Cells were examined using a confocal 
imaging system (MRC-600; Bio-Rad Laboratories). 
 
RT-PCR and real time PCR 
 
mRNAs was isolated from OCLs, and reverse-
transcribed by SuperScript III First-Strand Synthesis 
system for RT-PCR (Invitrogen), according to the 
manufacturer’s protocol. The primers we utilized to 
detect  bim and gapdh were as follows: bim: 5’-
ATGGCCAAGCAACC-TTCTGA-3’ (sense) and 5’-
GACCATACCTCTTCCGTAACT -3’ (antisense). gapdh: 
5’-GTATGTCGTGGAGTCTACTGGTGT-3’ (sense) and 
5’- CCGGATGTACCGGAGGTTCCTCAT-3’ (antisense). 
 
The primers utilized to detect, bax, bcl-xL were  as 
previously reported  by Okahashi et al. (22). Reverse 
transcribed mRNA were analyzed by ABI Prism® 7000 
Sequence Detection System (Applied Biosystems, CA). 
The primers we utilized in real time PCR to detect 
common form of all bim splice variants and bimEL specific 
form were as follows: bim  common form,  5’-
CTTCCATACGACAGTCTC-3’ (antisense). and 5’- 
CTTCTGGTGGGAGTTTACCAA-3’(antisense).  bimEL 
specific form, 5’-GTCCTCCAGTGGGTATTTCT (sense) 
and 5’-TCCTCCTTGGACTTCTAGAC-3’ (antisense). 
 
In situ hybridization 
 
Five-week-old male wild-type mice were sacrificed and 
the tibiae were fixed in 4% paraformaldehyde/PBS 
overnight at 4°C, processed, embedded in paraffin. 3-µm-
thick paraffin sections were cut, deparaffinized with 
Xylene and rehydrated with decreased concentrations of 
ethanol. The sections were then incubated overnight with     
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complementary  digoxigenin-labeled riboprobes for 
mouse bimL, procollagen type IA, and procollagen type 
IIA, followed by extensive washes to remove excess 
probe. Fluorescent-linked anti-digoxigenin antibodies are 
used to visualize the hybridized probe. 
 
In vivo BrdU labeling 
 
Five-week-old  bim+/+ and bim-/- mice were fed with 
water containing 1 mg/ml of 5’-bromo-2’-deoxyuridine 
(BrdU) for 1 week (labeling period). Mice were then 
sacrificed either on the next day (group A) or after 6 
weeks (group B) of the labeling period. The tibiae were 
removed and immersed in 4% buffered 
paraformaldehyde for paraffin sections. The sections 
were washed with PBS three times, treated with 2.5% 
hyaluronidase and blocked with 3% FBS in TBST for 30 
min. The sections were then incubated with the 
fluorescein-conjugated anti-BrdU antibody at a dilution 
of 1:50 overnight at 4°C. After washing with PBS, they 
were mounted in FluorSave. Sections were examined 
using a confocal imaging system (MRC-600; Bio-Rad 
Laboratories).  
 
Statistical analysis 
 
Each series of experiments was repeated at least three 
times. The results obtained from a typical experiment 
were expressed as the means ± SD (standard deviation). 
Significant differences were determined using factorial 
analysis of variance (ANOVA). 
 
RESULTS AND DISCUSSION 
 
Osteoclasts undergo spontaneous apoptosis without 
any cytokines or supporting cells 
 
To study the survival of osteoclasts in vitro, we used 
osteoclast-like cells (OCLs) purified from co-cultures by 
removing osteoblastic cells (18). The transduction of 
osteoclasts had been extremely difficult before we 
demonstrated that adenovirus vector-mediated gene 
delivery system can be successfully used to transduce 
foreign genes into osteoclasts both in vitro and in vivo 
(23, 24). We also found that ERK activity is important for 
osteoclast survival using adenovirus system. 
Downregulation of ERK activity by dominant negative 
Ras (RasDN) overexpression inhibited the survival of 
OCLs, whereas ERK activation after the introduction of 
constitutively active MEK (MEKCA) remarkably 
lengthened their survival (Fig. 1A). As shown in Fig. 1B, 
DNA fragmentation was observed in OCLs 24 h after 
purification by removing osteoblastic cells, indicating 
that OCLs undergo rapid apoptosis without any 
supporting cells or cytokines (20, 25, 26). We further 
determined that ~80% of the nuclei expressing RasDN 
underwent apoptosis after 12 h of the purification as 
shown in Fig. 1C by TUNEL staining. In contrast, 
positive TUNEL staining was hardly observed in MEKCA-
expressed OCLs even 24 h after the purification, 
indicating that Ras/ERK pathways greatly contribute to 
preventing apoptosis of osteoclasts. 
 
 
Fig. 1: Osteoclasts undergo spontaneous apoptosis. (A) After purification, 
non-infected OCLs or OCLs infected with Ax1w1, AxRasDN, or AxMEKCA 
were incubated with αMEM/10%FBS. The cultures remaining 18 h after 
purification were subjected to TRAP staining. (B) DNA ladder assay for 
apoptosis. Fragmentation of DNA in uninfected OCLs and OCLs infected 
with Ax1w1 was not detectable within 12 h, but observed after culturing 
for 24 h. DNA fragmentation was promoted in RasDN-expressed OCLs, and 
clear fragmentation was observed within 12 h. In contrast, DNA ladder 
formation, i.e. apoptosis, was strongly suppressed by expressing MEKCA. 
The 123-bp ladder DNA was used as a marker. (C) The TUNEL staining of 
MEKCA- or RasDN-expressed OCLs was conducted 24 or 12 h after the 
purification, respectively. Apoptotic cells were recognized by their dark 
nuclear staining (TUNEL-positive) and nuclei of nonapoptotic cells were 
visualized by staining with methyl green. Bar: 50 µm. (Ref. 20; Copyright 
2000. The Rockfeller University Press). 
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Rapid induction of Bim protein in purified OCLs 
 
Because osteoclasts contain abundant mitochondria that 
are involved in cytochrome c-mediated caspase-9 
activation,  we investigated whether mitochondrial 
pathways are involved in osteoclast apoptosis. As shown 
in Fig. 2A and B, depolarization of mitochondrial 
transmembrane potential, chromatin condensation and 
cytochrome c release from mitochondria into cytoplasm 
were observed in OCLs after purification. To further 
investigate the role of mitochondrial pathways in 
osteoclast survival, we examined the expression levels of 
pro- or anti-apoptotic Bcl-2 family members in purified 
OCLs. Immunoblot analysis revealed a significant 
increase in Bim expression levels in a time-dependent 
manner after removal of M-CSF, while those of Bid, Bax 
or Bcl-xL remained unchanged (15). Induction of Bim 
was reversed by M-CSF or, albeit less efficiently, by 
RANKL treatment (15). However, stimulation of M-CSF 
did not change bim m R N A  e x p r e s s i o n  i n  O C L s  ( 1 5 ) ,  
demonstrating that the changes in Bim protein levels are 
due to post-transcriptional mechanism. 
 
Ras/ERK pathway is involved in regulation of Bim in 
OCLs 
 
We found that the ERK pathway promotes survival of 
OCLs (20), while others found that the PI3-kinase/Akt 
pathway has an effect on this process (27, 28). To analyze 
whether these pathways are involved in downregulation 
of Bim, we used adenovirus vectors encoding 
constitutively active MEK1 (MEKCA) or Akt (myr-Akt), 
which contains a Src myristoylation signal that promotes 
association with the plasma membrane, causing 
constitutive activation. Enforced expression of MEKCA 
downregulated the expression level of Bim, while that of 
myr-Akt had less effect. These results indicate that 
Ras/ERK signaling is an important pathway for 
regulation of Bim expression level in OCLs (15). 
 
Bim deficiency promotes osteoclast survival in vitro 
 
To investigate the role of Bim in osteoclast apoptosis in 
vitro, we performed the OCL survival assay using bone 
marrow cells from bim-/- and bim+/+ mice. After 
purification by removing osteoblasts, bim-/- and bim+/+ 
OCLs were incubate with αMEM containing 10% FBS. 
Almost all bim+/+  OCLs disappeared within 24 hours, 
whereas more than 90% of bim-/- OCLs remained alive. 
The elongated survival of bim-/- OCLs was abrogated by 
the overexpression of Bim with adenovirus vector (15). 
These results indicate that the expression level of Bim 
play a critical role in spontaneous apoptosis of 
osteoclasts.  
 
 
Fig. 2: Mitochondrial pathway is involved in osteoclast apoptosis. (A) The 
nuclei of purified OCLs at time zero were stained uniformly with Hoechst 
33258, whereas fragmentation and condensation of nuclei were observed 
24 h after the purification. MitoRed staining, an indicator of mitochondrial 
membrane potential, was markedly decreased in OCLs 24 h after 
purification, as compared to the staining at time zero. MitoGreen, which 
preferentially accumulates in mitochondria regardless of mitochondrial 
membrane potential, was used to detect the localization of mitochondria. 
Bar: 10 µm. (B) Subcellular fractionation of purified OCLs. Cell 
membranes were fractionated by ApoAlert Cell Fractionation Kit and the 
resulting fractions were immunoblotted with anti-cytochrome c antibody. 
Release of cytochrome c from mitochondria to cytosol was increased in a 
time-dependent manner. 
 
Expression of Bim in skeletal tissues 
 
To analyze the expression of bim in skeletal tissues in 
vivo, we performed in situ hybridization analysis using a 
bimL antisense probe which detects bimS,  bimL and 
bimEL. Bim mRNA was strongly expressed in the bone 
trabeculae of 5-week-old male mouse metatarsal bone, 
which was co-localized with tartrate-resistant acid 
phosphatase (TRAP) enzymatic staining, i.e. with 
osteoclasts (Fig. 3). We used bone sections from bim-    
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deficient mice as negative controls (data not shown). On 
the other hand, bim transcripts were hardly detectable in 
osteoblasts or chondrocytes, whose localization was 
determined by procollagen type IA and type IIA 
expression, respectively (Fig. 3). The expression pattern 
of bim in the skeletal tissues was confirmed further by X-
gal staining of mutant mice, in which a lacZ reporter 
gene was knocked into the bim locus by homologous 
recombination (Fig. 3). 
 
 
Fig. 3: In situ hybridization of the section of the metatarsal bones from 5-
week-old male wild type mouse using digoxigenin-labeled mouse bimL (B), 
procollagen type IA (C) and type II A (D) riboprobes, and TRAP enzymatic 
staining (A). The labeling was detected by anti-digoxigenin antibody and 
Alexa 488-labeled anti-rabbit IgG antibody. Note the colocalization of bim 
transcripts with TRAP staining (osteoclasts) (A & B). No positive bimL 
staining was colocalized with procollagen type IA staining (osteoblasts) or 
type IIB staining (chondrocytes). X-gal staining of the tibiae from 5-week-
old transgenic mice in which lacZ gene was introduced into the bim locus 
by homologous recombination also showed the clear positive staining in 
osteoclasts but not in chondrocytes or osteoblasts (E). Bar: 100 µm. (Ref. 
15; Copyright 2003. The European Molecular Biology Organization). 
Elongated life span of bim-/- osteoclasts in vivo 
 
We next examined whether bim-/- osteoclasts have a 
longer life span in vivo. Five-week-old bim+/+ and bim-/- 
mice were fed with water containing 1 mg/ml of BrdU 
for 1 week (labeling period). Mice were then sacrificed 
either on the next day (group A) or after 6 weeks (group 
B) of the labeling period. Immunostaining with anti-
BrdU antibody demonstrated that almost similar 
proportions of osteoclasts were positively stained in 
group A bim+/+ and bim-/- mice (50 and 48%, 
respectively). However, the proportion of BrdU-positive 
osteoclasts was markedly decreased to < 5% in group B 
bim+/+ mice, while that in group B bim-/- mice was 
maintained at 33% (Fig. 4). This suggests that bim-/- 
osteoclasts have a longer life span than bim+/+ osteoclasts 
in vivo. 
 
 
Fig. 4: bim-/- osteoclasts have longer life span in vivo. (A) Five-week-old 
bim+/+ and bim-/- mice (n=4) were fed with water containing 1 mg/ml 
BrdU for 1 week (labeling period). Mice were then sacrificed either on the 
next day (group A) or after 6 weeks (group B) of the labeling period, and 
their tibia were examined by anti-BrdU immunohistochemistry. Bar: 100 
µm. (B) More than 100 osteoclasts were examined by BrdU 
immunostaining in the serial sections of tibia, and the number of BrdU-
positive osteoclasts was counted. 50% of bim+/+ osteoclasts and 48% of 
bim-/- osteoclasts in group A were positively stained by BrdU. However, 
the proportion of BrdU-positive osteoclasts was markedly reduced to less 
than 5% in group B bim+/+ mice, due to the apoptotic cell death, while 
more than 30% of group B bim-/- osteoclasts still exhibited BrdU labeling. 
NS = not significantly different. *Significantly different, P < 0.005. (Ref. 
15; Copyright 2003. The European Molecular Biology Organization).     
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M-CSF stimulation promotes ubiquitylation-dependent 
degradation of Bim in OCLs 
 
Induction of Bim protein without changes in mRNA 
expression levels suggested that Bim is regulated post-
transcriptionally and rapidly. To elucidate the detail of 
Bim regulation, we investigated the effect of proteasome 
inhibitors, such as lactacystin or MG132, on Bim 
expression level in OCLs. Interestingly, treatment with 
these inhibitors greatly enhanced the expression of Bim 
both in OCLs and their precursors. This indicates that the 
ubiquitin/proteasome degradation system is involved in 
the regulation of Bim expression in these cells. In fact, 
immunoprecipitation of Bim followed by immunoblot 
analysis using anti-ubiquitin antibody demonstrated a 
high level of Bim poly-ubiquitylation in OCLs cultured 
in M-CSF, which was reduced after M-CSF removal (15). 
Furthermore, we found that Bim is associated with c-Cbl 
and that overexpression of c-Cbl suppressed the 
expression of Bim by promoting its ubiquitylation, while 
that of v-Cbl, which can act in a dominant-negative 
fashion, increased Bim level even in the presence of M-
CSF, indicating the important role of c-Cbl in Bim 
ubiquitylation (15).  
 
Retrovirus-mediated Bim mutant expression in 
osteoclast precursors 
 
One of the first steps in the ubiquitin/proteasome 
degradation system includes selective modification of ε-
NH2 groups of lysine residues by ubiquitylation. We 
constructed retroviral vectors encoding wild type (wt) or 
mutated (mt) BimEL, which lacks all the ubiquitin 
acceptor lysine residues (Lys3 and Lys108). The both 
lysine residues are mutated to arginine. These vectors 
contain EGFP tracer that enables to detect the infected 
cells.  bim-/- osteoclast precursors were infected either 
with control virus (pMX-IRES-EGFP), pMxBimEL-IRES-
EGFP or pMxmtBimEL-IRES-EGFP in the presence of M-
CSF and a pan-caspase inhibitor zVAD-FMK. Removal of 
zVAD-FMK induced rapid apoptosis in the cells 
expressing mtBimEL within 18 h even in the presence of 
M-CSF, while almost all control virus- or 77% of pMx-
IRES-BimEL-infected cells survived for at least 24 h. 
Removal of both zVAD-FMK and M-CSF caused 
apoptosis in BimEL and mtBimEL-expressing cells (Fig. 
5A). MG132 treatment clearly upregulated the expression 
of wtBimEL, while it did not affect mtBim expression (Fig. 
5C). Immunoprecipitated mtBim was not ubiquitinated 
even in the presence of M-CSF and MG132, as compared 
to wtBim (Fig. 5D). These results indicate that 
ubiquitylation and proteasome-mediated degradation 
are critical modulators of the pro-apoptotic cascades 
regulated by Bim, at least in osteoclasts and their 
precursors. 
 
 
Fig. 5: Effect of mutations in Bim that prevent ubiquitylation. (A) Phase 
contrast (a, c, & e) and immunofluorescence microscopy.: bim-/- bone 
marrow cells cultured in the presence of M-CSF were infected with either 
pMx-IRES-EGFP, pMxBimEL-IRES-EGFP or pMxmtBimEL-IRES-EGFP: zVAD-
FMK was added just after the retroviral infection. After 7 days of the 
retrovirus infection, when gene expression was confirmed by EGFP 
fluorescence (b, d, & f), cultures were deprived of zVAD-FMK. Eighteen 
hours after zVAD-FMK removal, more than 70% of pMx-IRES-EGFP- and 
pMxBimEL-IRES-EGFP-infected cells survived as identified by EGFP 
fluorescence (h and j), compared to the survival rate of 5% in 
pMxmtBimEL-IRES-EGFP virus-infected cells (l). Both pMxBimEL-IRES-EGFP- 
or pMxmtBimEL-IRES-EGFP-infected cells died when M-CSF was removed 
from the cultures (i & k). Bar: 50 µm. (B) The survival ratio of EGFP 
positive cells. Almost 100% of the control cells survived even 18h after z-
VAD-FMK removal in the presence of M-CSF. 18 hours after zVAD-FMK 
removal, more than 70% of pMx-IRES-EGFP- and pMxBimEL-IRES-EGFP-
infected cells survived as identified by EGFP fluorescence (EGFP and 
wtBimEL), compared to the survival rate of 5% in pMxmtBimEL-IRES-EGFP 
virus-infected cells (mtBimEL). (C) The proteasome inhibitors MG132 
enhanced the expression level of wtBim in pMxBimEL-IRES-EGFP-infected 
OC precursors even in the presence of M-CSF, while no obvious 
upregulation of mtBim was observed in pMxmtBimEL-IRES-EGFP infected 
cells. (D) WtBim or mtBim was immunoprecipitated from cell lysates of 
pMxBimEL-IRES-EGFP-infected or pMxmtBimEL-IRES-EGFP-infected cells 
using anti-Bim polyclonal antibody, and the immunoprecipitates were 
immunoblotted with anti-ubiquitin antibody. Treating the cells with the 
proteasome inhibitor MG132 strongly increased the ubiquitination of Bim, 
while no ubiquitination of mtBim was observed. (Ref. 15; Copyright 2003. 
The European Molecular Biology Organization). 
 
In summary, our experiments highlight that a 
combination of adenovirus and retrovirus-mediated gene 
transfer into osteoclasts and their precursors can be 
powerful tools for studying osteoclast function such as 
their survival and bone resorbing activity. Adenovirus 
vectors are also useful for in vitro gene transfer to 
cultured osteoblasts, chondrocytes and synoviocytes, and     
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moreover, they are one of the most efficient vectors for in 
vivo gene delivery into intra-articular tissues including 
synovium (24). We also established the modified 
protocols for in situ hybridization and BrdU labeling of 
bone sections from mice. These methods enabled us to 
obtain a new insight into the molecular mechanism and 
dynamics of bone homeostasis and inflammatory 
diseases leading to progressive bone and joint 
destruction. 
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PROTOCOLS 
 
Adenovirus infection 
 
Day 0: Seed 1.5 × 106 osteoblastic cells in 10 cm tissue culture dishes in 10 ml αMEM/10%FBS containing 10 nM 
1α,25(OH)2D3 and 1 µM PGE2. 
Day 1: Aspirate off media and start coculture by adding 1.5 × 107 bone marrow cells in 10 ml fresh media with 
1α,25(OH)2D3 and PGE2. 
Day 3: Add only 5 ml fresh media containing 1α,25(OH)2D3 and PGE2 without aspirating medium. 
Day 5: Aspirate media and add 1ml of αMEM containing the recombinant adenovirus at an indicated MOI. Then 
incubate at 37°C for 1 h with intermittent shaking. Wash twice with PBS and further incubated at 37°C in 
αMEM/10%FBS containing 10 nM 1α,25(OH)2D3 and 1 µM PGE2. 
Day 6: Aspirate medium and wash twice with PBS. Add 5 ml of αMEM containing 0.1% collagenase and 0.2% dispase 
and incubate for 10 min at 37°C. Tap the dishes to remove osteoblastic cells. The purity of OCLs was > 90% at the final 
preparation. Carefully wash twice with αMEM without injuring purified OCLs. Then start the experiments using the 
purified OCLs. 
 
Retrovirus infection 
 
Day 0: Seed 1.0 × 107 bone marrow cells in 6 cm tissue culture dishes in 10 ml αMEM/10%FBS with mouse 
recombinant M-CSF (50ng/ml). 
Day 2: Aspirate off media and incubate with 1 ml of αMEM containing the retrovirus at an indicated MOI for 4 h in 
the presence of mouse recombinant M-CSF (50 ng/ml) and polybrene (8 µg/ml). Wash twice with PBS and further 
incubated at 37°C in αMEM/10%FBS containing 100 ng/ml M-CSF. 
Day 4, 6, 8: Aspirate off media and replace with fresh complete media. 
Day 9: Start the experiments using retrovirus-infected bone marrow macrophage. 
 
In situ hybridization 
 
1. Place slides in RNase-free glass coplin jars.  
2. Deparaffinize and rehydrate in:  
•  xylene for 3 X 2 minutes 
•  100% EtOH for 3 X 1 minutes 
•  95% EtOH for 1 X1 minutes 
•  70% EtOH for 1 X 1 minutes 
•  1XPBS for 1 X 1 minutes. 
3. Fix sections with 4% paraformaldehyde buffered with PBS (PFA-PBS) for 15 min at room temperature. 
4. Wash in 1X PBS for 5 minutes.  
5. Digest slides with 10 µg/ml proteinase K for 15 min in PBS.  
6. Treat again with 4% PFA-PBS for 10 min to inactivate proteinase K 
7. Wash in 1X PBS for 3 minutes.  
8. Incubate with 0.2 N HCl for 10 minutes 
9. Wash in 1X PBS for 5 minutes. 
10. Acetylate slides with 0.3% acetic anhydride in the presence of 0.1 M triethanolamine for 10 min. 
11. Treat with 3% hydrogen peroxide/methanol for 30 min. Dehydrate with: 
•  1XPBS for 1 X 5 minutes 
•  70% EtOH for 1 X 3 minutes 
•  95% EtOH for 1 X 3 minutes and air dried.     
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12.  Add 28.5 µl hybridization buffer to 1.5 µl probe solution and mix thoroughly. 
13.  Boil hybridization solution for 5 minutes, place on ice.  
14.  Pipette hybridization solution onto section.  
15.  Place in a prewarmed humidity chamber and incubate for 18 hours at 52°C.  
16.  Preheat 200 ml 2XSSC to 52°C.  
17.  Remove slides from the humidity chamber and place in Coplin jars.  
18.  Wash slides in 2XSSC for 2 X 1 minutes.  
19.  Treat tissues with RNase A 30 µg / ml / 2XSSC for 30 minutes at 37°C.  
20.  Wash slides in 2XSSC for 2 X 1 min.  
21.  Incubate in 50% formamide / 2XSSC for 5 minutes at 52°C.  
22.  Wash slides in 3 X TBS-T for 3 min.  
23.  Block slides by PBS containing 1% bovine serum albumin for 10 minutes.  
24.  Incubate with HRP-conjugated anti-DIG rabbit polyclonal antibody at a dilution of 1:100 for 24 h at 4°C. 
25.  Return slides to a Coplin jar and wash in DIG I buffer for 10 minutes. Repeat.  
26.  Wash slides in 3 X TBS-T for 3 min.  
27.  Immersed slides in a diaminobenzidine solution for 5-10 min at room temperature to visualize immunoreactivity.  
28.  Wash slides in water for 3 min 
29.  Counterstain in methylgreen for 1 to 2 minutes  
30.  Rinse thoroughly in running water.  
31.  Coverslip slides with permanent mounting media. 
 
In vivo BrdU labeling 
 
1.  Feed 5-week-old bim+/+ and bim-/- mice with water containing 1 mg/ml of 5’-bromo-2’-deoxyuridine (BrdU) for 1 
week (labeling period). Replace with fresh BrdU water every other day. 
2.  Remove the tibiae and fix in 4% paraformaldehyde/PBS at 4°C for 8 hours.  
3.  Embed the tibiae in paraffin and section paraffin-embedded samples 3-mm-thick. 
4.  Place slides in glass coplin jars.  
5.  Deparaffinize and rehydrate in: 
•  xylene for 3 X 2 minutes 
•  100% EtOH for 3 X 1 minutes 
•  95% EtOH for 1 X 1 minutes 
•  70% EtOH for 1 X 1 minutes 
•  1XPBS for 3 X 1 minutes. 
6.  Treat with 2.5% hyaluronidase and block with 3% FBS in TBST for 30 min at room temperature.  
7.  Incubate sections with the fluorescein-conjugated anti BrdU antibody at a dilution of 1:50 overnight at 4°C. 
8.  Wash with PBS for 5min three times. 
9.  Coverslip slides with FluorSave.  
10.  Examine the sections using a confocal imaging system (MRC-600; Bio-Rad Laboratories).  
 